Magdy El-Salhy

Professor/consultant gastroenterologist

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Magdy El-Salhy is a consultant gastroenterologist at the University of Bergen, Norway. His research primarily focuses on fecal microbiota transplantation and its efficacy in treating irritable bowel syndrome (IBS), including factors influencing patient response and long-term outcomes. He has contributed significantly to the understanding of the microbiota's role in IBS, as evidenced by his recent publications addressing symptom variability and potential treatment protocols.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Jørgen Valeur

Head of Department

NORWAY

View details

Odd Helge Gilja

Haukeland University Hospital

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Magdy El-Salhy

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms

Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue

Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome

Letter: A step forward towards a standard FMT protocol for IBS

Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation

The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation

Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation

Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome

Current status of fecal microbiota transplantation for irritable bowel syndrome

The role of diet in the pathophysiology and management of irritable bowel syndrome

FMT in IBS: how cautious should we be?

Collaborators (2)

Jørgen Valeur

Odd Helge Gilja

Make your next move.